GAMMA N-HANCE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2010-04-30 for GAMMA N-HANCE manufactured by Immucor.

Event Text Entries

[1301337] Customer reported a patient sample with multiple antibodies was nonreactive when testing was performed using gamma n-hance. The patient has a history of anti-k, anti-c, anti-e and a warm autoantibody.
Patient Sequence No: 1, Text Type: D, B5


[8473559] Review of antibody screen with n-hance shows that all cells resulted negative. Tested a sample with known igg antibody (anti-fya) using retention n-hance, lot 335007 and without n-hance as the potentiator, using retention panoscreen i, ii and iii. The antibody was enhanced from 2+ to 3+ reactivity with the use of retention n-hance as the potentiator at the indirect antiglobulin test. Retention products performed as expected. Tested a sample with known igg antibody (anti-fya) using returned n-hance, lot 335007 and without n-hance as the potentiator on retention panoscreen i, ii and iii. The antibody was enhanced from 2+ to 3+ reactivity with the use of returned n-hance as the potentiator at the indirect antiglobulin test. Returned products performed as expected. The submitted patient sample was tested with retention panoscreen i, ii and iii using three sets of testing parameters: set a -without n-hance; set b - with retention n-hance; set c - with returned h-hance. The results were as follows: set a - the sample exhibited no reactivity macro/micro at the indirect antiglobulin test (iat) set b - the sample exhibited very weak to microscopic reactivity with cell i, e-,c-, k- reagent red cells only. No reactivity was observed with cell ii and iii. Set c - the same reactivity was observed as set b. The returned sample was tested with retention panoscreen i, ii and iii using retention peg. The sample exhibited weak reactivity with cell i and ii and 1+ reactivity with cell iii. The sample was tested with retention capture-r ready screen 3 , lot r084 on our in-house echo. The sample exhibited 4+ reactivity with all three reagent red cells. It appears that based on the above results, the antibody that is very weakly detected with returned and retention n-hance is the warm auto antibody. Previous anti-e, -c and -k were not detected. The warm auto antibody was also detected weakly using peg and in capture assay.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1034569-2010-00104
MDR Report Key1670620
Report Source05,06
Date Received2010-04-30
Date of Report2010-04-29
Date of Event2010-04-02
Date Mfgr Received2010-04-02
Date Added to Maude2010-11-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactMR. J. WEBBER
Manufacturer StreetIMMUCOR 3150 GATEWAY DRIVE
Manufacturer CityNORCROSS GA 30091
Manufacturer CountryUS
Manufacturer Postal30091
Manufacturer Phone7704412051
Manufacturer G1IMMUCOR
Manufacturer Street3130 GATEWAY DRIVE
Manufacturer CityNORCROSS GA 30091
Manufacturer CountryUS
Manufacturer Postal Code30091
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameGAMMA N-HANCE
Generic NamePOTENTIATING MEDIA FOR IN-VITRO DIAGNOSTIC USE
Product CodeKSG
Date Received2010-04-30
Returned To Mfg2010-04-02
Lot Number335007
Device Expiration Date2012-05-29
OperatorMEDICAL TECHNOLOGIST
Device AvailabilityR
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerIMMUCOR
Manufacturer Address3130 GATEWAY DRIVE NORCROSS GA 30071 US 30071


Patients

Patient NumberTreatmentOutcomeDate
10 2010-04-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.